Vedere Bio

Vedere Bio is a privately held, emerging biopharmaceutical company discovering and developing next generation ocular gene therapies to make vision restoration a reality. Vedere is developing a pipeline of novel vision restoration and preservation therapies that will bring life-changing technology to a global unmet medical need.

Headquarters Cambridge, MA
Pipeline Status Preclinical
Twitter @VedereBio
LinkedIn Vedere Bio